Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Valeant's Allergan bid gets hostile as Ackman makes a play for board control

02.06.2014 / Fierce Pharma

Valeant CEO J. Michael Pearson and the company's largest shareholder, Bill Ackman, have been trying to propel Allergan's board toward deal negotiations ever since they announced their first unsolicited bid back in April. And now, they're adding a little extra incentive.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: